{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T14:40:20Z","timestamp":1792593620391,"version":"4.5.0"},"reference-count":45,"publisher":"MyJove Corporation","issue":"227","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JoVE"],"DOI":"10.3791\/69263","type":"journal-article","created":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T00:01:14Z","timestamp":1767744074000},"source":"Crossref","is-referenced-by-count":0,"title":["Influence of Efgartigimod on Curative Efficacy and Inflammation Factors of Patients with Long Segmental Myelitis"],"prefix":"10.3791","author":[{"given":"Lei","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun-Ming","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2098","published-online":{"date-parts":[[2026,1,6]]},"reference":[{"issue":"9","key":"ref1","first-page":"e68778","type":"journal-article","article-title":"Integrated Rehabilitation of Longitudinal Extensive Transverse Myelitis: Study of a Complex Case","volume":"16","author":"Qureshi","year":"2024","unstructured":"Qureshi, M. G., Harjpal, P., Nawkhare, A. V., Saklecha, A., Seth, N. H. Integrated Rehabilitation of Longitudinal Extensive Transverse Myelitis: Study of a Complex Case. Cureus. 16 (9), e68778 (2024).","journal-title":"Cureus"},{"issue":"1","key":"ref2","doi-asserted-by":"crossref","first-page":"e14973","DOI":"10.1111\/1756-185X.14973","type":"journal-article","article-title":"Neuromyelitis optica spectrum disorders (NMOSD) and systemic lupus erythematosus (SLE): Dangerous duo","volume":"27","author":"Abou Raya","year":"2024","unstructured":"Abou Raya, A., Raya, S. A. Neuromyelitis optica spectrum disorders (NMOSD) and systemic lupus erythematosus (SLE): Dangerous duo. Int J Rheumatic Dis. 27 (1), e14973 (2024).","journal-title":"Int J Rheumatic Dis"},{"issue":"4","key":"ref3","doi-asserted-by":"crossref","first-page":"e40","DOI":"10.1212\/NXI.0000000000000040","type":"journal-article","article-title":"Antibodies to myelin oligodendrocyte glycoprotein in bilateral and recurrent optic neuritis","volume":"1","author":"Ramanathan","year":"2014","unstructured":"Ramanathan, S. et al. Antibodies to myelin oligodendrocyte glycoprotein in bilateral and recurrent optic neuritis. Neurol Neuroimmunol Neuroinflammat. 1 (4), e40 (2014).","journal-title":"Neurol Neuroimmunol Neuroinflammat"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.jneuroim.2018.05.005","type":"journal-article","article-title":"Long-term outcomes of varicella zoster virus infection-related myelitis in 10 immunocompetent patients","volume":"321","author":"Wang","year":"2018","unstructured":"Wang, X. et al. Long-term outcomes of varicella zoster virus infection-related myelitis in 10 immunocompetent patients. J Neuroimmunol. 321, 36-40 (2018).","journal-title":"J Neuroimmunol"},{"issue":"1","key":"ref5","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ijcard.2010.08.070","type":"journal-article","article-title":"Corticosteroid administration for patients with coronary artery aneurysms after Kawasaki disease may be associated with impaired regression","volume":"154","author":"Millar","year":"2012","unstructured":"Millar, K., Manlhiot, C., Yeung, R. S., Somji, Z., McCrindle, B. W. Corticosteroid administration for patients with coronary artery aneurysms after Kawasaki disease may be associated with impaired regression. Int J Cardiol. 154 (1), 9-13 (2012).","journal-title":"Int J Cardiol"},{"issue":"10","key":"ref6","doi-asserted-by":"crossref","first-page":"e036643","DOI":"10.1136\/bmjopen-2019-036643","type":"journal-article","article-title":"open-label, non-inferiority trial comparing the effectiveness and safety of ductal lavage versus oral corticosteroids for idiopathic granulomatous mastitis: a study protocol","volume":"10","author":"Hu","year":"2020","unstructured":"Hu, T. et al. Multicentre, randomised, open-label, non-inferiority trial comparing the effectiveness and safety of ductal lavage versus oral corticosteroids for idiopathic granulomatous mastitis: a study protocol. BMJ Open. 10 (10), e036643 (2020).","journal-title":"BMJ Open"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.msard.2017.09.015","type":"journal-article","article-title":"Diagnosis and management of Neuromyelitis Optica Spectrum Disorder (NMOSD) in Iran: A consensus guideline and recommendations","volume":"18","author":"Sahraian","year":"2017","unstructured":"Sahraian, M. A. et al. Diagnosis and management of Neuromyelitis Optica Spectrum Disorder (NMOSD) in Iran: A consensus guideline and recommendations. Mult Scler Relat Disord. 18, 144-151 (2017).","journal-title":"Mult Scler Relat Disord"},{"issue":"9","key":"ref8","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1007\/s10072-019-03935-y","type":"journal-article","article-title":"Myelopathy associated with mixed connective tissue disease: clinical manifestation, diagnosis, treatment, and prognosis","volume":"40","author":"Hao","year":"2019","unstructured":"Hao, Y., Xin, M., Wang, S., Ma, D., Feng, J. Myelopathy associated with mixed connective tissue disease: clinical manifestation, diagnosis, treatment, and prognosis. Neurol Sci. 40 (9), 1785-1797 (2019).","journal-title":"Neurol Sci"},{"issue":"3","key":"ref9","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/jns.12282","type":"journal-article","article-title":"Conventional and unconventional therapies in typical and atypical chronic inflammatory demyelinating polyneuropathy with different clinical course of progression","volume":"23","author":"Hung","year":"2018","unstructured":"Hung, S. K. Y., Hiew, F. L., Viswanathan, S., Puvanarajah, S. Conventional and unconventional therapies in typical and atypical chronic inflammatory demyelinating polyneuropathy with different clinical course of progression. J Peripheral Nervous Sys. 23 (3), 183-189 (2018).","journal-title":"J Peripheral Nervous Sys"},{"issue":"8","key":"ref10","doi-asserted-by":"crossref","first-page":"764","DOI":"10.3390\/brainsci14080764","type":"journal-article","article-title":"Unravelling the Acute, Chronic and Steroid-Refractory Management of High-Grade Neurological Immune-Related Adverse Events: A Call to Action","volume":"14","author":"Malvaso","year":"2024","unstructured":"Malvaso, A. et al. Unravelling the Acute, Chronic and Steroid-Refractory Management of High-Grade Neurological Immune-Related Adverse Events: A Call to Action. Brain Sci. 14 (8), 764 (2024).","journal-title":"Brain Sci"},{"issue":"2","key":"ref11","doi-asserted-by":"crossref","first-page":"169","DOI":"10.7861\/clinmedicine.19-2-169","type":"journal-article","article-title":"Neuromyelitis optica spectrum disorders","volume":"19","author":"Huda","year":"2019","unstructured":"Huda, S. et al. Neuromyelitis optica spectrum disorders. Clin Med (Lond). 19 (2), 169-176 (2019).","journal-title":"Clin Med (Lond)"},{"issue":"6","key":"ref12","doi-asserted-by":"crossref","first-page":"942","DOI":"10.3390\/cells11060942","type":"journal-article","article-title":"Stabilization of Keratinocyte Monolayer Integrity in the Presence of Anti-Desmoglein-3 Antibodies through FcRn Blockade with Efgartigimod: Novel Treatment Paradigm for Pemphigus","volume":"11","author":"Zakrzewicz","year":"2022","unstructured":"Zakrzewicz, A. et al. Stabilization of Keratinocyte Monolayer Integrity in the Presence of Anti-Desmoglein-3 Antibodies through FcRn Blockade with Efgartigimod: Novel Treatment Paradigm for Pemphigus? Cells. 11 (6), 942 (2022).","journal-title":"Cells"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1473637","DOI":"10.3389\/fimmu.2024.1473637","type":"journal-article","article-title":"Binding to the neonatal Fc receptor enhances the pathogenicity of anti-desmoglein-3 antibodies in keratinocytes","volume":"15","author":"Zakrzewicz","year":"2024","unstructured":"Zakrzewicz, A. et al. Binding to the neonatal Fc receptor enhances the pathogenicity of anti-desmoglein-3 antibodies in keratinocytes. Front Immunol.15 1473637 (2024).","journal-title":"Front Immunol"},{"issue":"5","key":"ref14","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1002\/mus.27974","type":"journal-article","article-title":"Safety and outcomes with efgartigimod use for acetylcholine receptor-positive generalized myasthenia gravis in clinical practice","volume":"68","author":"Katyal","year":"2023","unstructured":"Katyal, N. et al. Safety and outcomes with efgartigimod use for acetylcholine receptor-positive generalized myasthenia gravis in clinical practice. Muscle Nerve. 68 (5), 762-766 (2023).","journal-title":"Muscle Nerve"},{"issue":"11","key":"ref15","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1007\/s40265-024-02101-9","type":"journal-article","article-title":"Efgartigimod: A Review in Generalised Myasthenia Gravis","volume":"84","author":"Blair","year":"2024","unstructured":"Blair, H. A. Efgartigimod: A Review in Generalised Myasthenia Gravis. Drugs. 84 (11), 1463-1474 (2024).","journal-title":"Drugs"},{"issue":"9","key":"ref16","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1002\/acn3.70156","type":"journal-article","article-title":"Efgartigimod Combined With Steroid Treatment for HAM\/TSP: A Case Report","volume":"12","author":"Zeng","year":"2025","unstructured":"Zeng, J. et al. Efgartigimod Combined With Steroid Treatment for HAM\/TSP: A Case Report. Ann Clin Transl Neurol. 12 (9), 1937-1941 (2025).","journal-title":"Ann Clin Transl Neurol"},{"issue":"5","key":"ref17","doi-asserted-by":"crossref","first-page":"e00378","DOI":"10.1016\/j.neurot.2024.e00378","type":"journal-article","article-title":"Subcutaneous efgartigimod PH20 in generalized myasthenia gravis: A phase 3 randomized noninferiority study (ADAPT-SC) and interim analyses of a long-term open-label extension study (ADAPT-SC+)","volume":"21","author":"Howard","year":"2024","unstructured":"Howard, J. F., Jr. et al. Subcutaneous efgartigimod PH20 in generalized myasthenia gravis: A phase 3 randomized noninferiority study (ADAPT-SC) and interim analyses of a long-term open-label extension study (ADAPT-SC+). Neurotherapeutics. 21 (5), e00378 (2024).","journal-title":"Neurotherapeutics"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.pediatrneurol.2020.01.007","type":"journal-article","article-title":"Acute Flaccid Myelitis Among Hospitalized Children in Texas, 2016","volume":"106","author":"Downey","year":"2020","unstructured":"Downey, R. et al. Acute Flaccid Myelitis Among Hospitalized Children in Texas, 2016. Pediatr Neurol. 106, 50-55 (2020).","journal-title":"Pediatr Neurol"},{"issue":"5","key":"ref19","doi-asserted-by":"crossref","first-page":"104","DOI":"10.3892\/etm.2020.9234","type":"journal-article","article-title":"Clinical efficacy of \u03b3-globulin combined with dexamethasone and methylprednisolone, respectively, in the treatment of acute transverse myelitis and its effects on immune function and quality of life","volume":"20","author":"Wang","year":"2020","unstructured":"Wang, P. et al. Clinical efficacy of \u03b3-globulin combined with dexamethasone and methylprednisolone, respectively, in the treatment of acute transverse myelitis and its effects on immune function and quality of life. Exp Ther Med. 20 (5), 104 (2020).","journal-title":"Exp Ther Med"},{"issue":"22","key":"ref20","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.3109\/09638288.2013.766269","type":"journal-article","article-title":"Comparison of the Kurtkze expanded disability status scale and the functional independence measure: measures of multiple sclerosis-related disability","volume":"35","author":"Rabadi","year":"2013","unstructured":"Rabadi, M. H., Vincent, A. S. Comparison of the Kurtkze expanded disability status scale and the functional independence measure: measures of multiple sclerosis-related disability. Disabil Rehabil. 35 (22), 1877-1884 (2013).","journal-title":"Disabil Rehabil"},{"issue":"3","key":"ref21","doi-asserted-by":"crossref","first-page":"210","DOI":"10.5770\/cgj.23.463","type":"journal-article","article-title":"Using the Clinical Frailty Scale in Allocating Scarce Health Care Resources","volume":"23","author":"Rockwood","year":"2020","unstructured":"Rockwood, K., Theou, O. Using the Clinical Frailty Scale in Allocating Scarce Health Care Resources. Can Geriatr J. 23 (3), 210-215 (2020).","journal-title":"Can Geriatr J"},{"issue":"6846","key":"ref22","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1136\/bmj.305.6846.160","type":"journal-article","article-title":"Validating the SF-36 health survey questionnaire: new outcome measure for primary care","volume":"305","author":"Brazier","year":"1992","unstructured":"Brazier, J. E. et al. Validating the SF-36 health survey questionnaire: new outcome measure for primary care. Bmj. 305 (6846), 160-164 (1992).","journal-title":"Bmj"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"103470","DOI":"10.1016\/j.bjid.2023.103470","type":"journal-article","article-title":"Myelite transverse due to herpes virus: Case report","volume":"27","author":"Zinelli","year":"2023","unstructured":"Zinelli, G. D., Alt, M. C. R., Menezes, B. K., Buffon, V. R. Myelite transverse due to herpes virus: Case report. Brazilian J Infectious Dis. 27, 103470 (2023).","journal-title":"Brazilian J Infectious Dis"},{"issue":"9","key":"ref24","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1038\/sj.sc.3100894","type":"journal-article","article-title":"Clinical and evoked potential changes in acute transverse myelitis following methyl prednisolone","volume":"37","author":"Kalita","year":"1999","unstructured":"Kalita, J., Guptar, P. M., Misra, U. K. Clinical and evoked potential changes in acute transverse myelitis following methyl prednisolone. Spinal Cord. 37 (9), 658-662 (1999).","journal-title":"Spinal Cord"},{"issue":"2","key":"ref25","first-page":"e54074","type":"journal-article","article-title":"Acute Transverse Myelitis as an Unusual Complication of Dengue Fever: A Case Report and Literature Review","volume":"16","author":"Karishma","year":"2024","unstructured":"Karishma, F. N. U. et al. Acute Transverse Myelitis as an Unusual Complication of Dengue Fever: A Case Report and Literature Review. Cureus. 16 (2), e54074 (2024).","journal-title":"Cureus"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"577704","DOI":"10.1016\/j.jneuroim.2021.577704","type":"journal-article","article-title":"Longitudinally extensive transverse myelitis as a sign of multisystem inflammatory syndrome following COVID-19 infection: A pediatric case report","volume":"360","author":"Pourmoghaddas","year":"2021","unstructured":"Pourmoghaddas, Z. et al. Longitudinally extensive transverse myelitis as a sign of multisystem inflammatory syndrome following COVID-19 infection: A pediatric case report. J Neuroimmunol. 360, 577704 (2021).","journal-title":"J Neuroimmunol"},{"issue":"23","key":"ref27","doi-asserted-by":"crossref","first-page":"e2661","DOI":"10.1212\/WNL.0000000000007600","type":"journal-article","article-title":"Randomized phase 2 study of FcRn antagonist efgartigimod in generalized myasthenia gravis","volume":"92","author":"Howard","year":"2019","unstructured":"Howard, J. F. et al. Randomized phase 2 study of FcRn antagonist efgartigimod in generalized myasthenia gravis. Neurology. 92 (23), e2661-e2673 (2019).","journal-title":"Neurology"},{"issue":"9","key":"ref28","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1080\/1744666X.2022.2106972","type":"journal-article","article-title":"Abdeg technology for the treatment of myasthenia gravis: efgartigimod drug experience","volume":"18","author":"Dos Santos","year":"2022","unstructured":"Dos Santos, J. B. R., Gomes, R. M., da Silva, M. R. R. Abdeg technology for the treatment of myasthenia gravis: efgartigimod drug experience. Expert Rev Clin Immunol. 18 (9), 879-888 (2022).","journal-title":"Expert Rev Clin Immunol"},{"issue":"2","key":"ref29","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.msard.2015.02.003","type":"journal-article","article-title":"On the origin of EDSS","volume":"4","author":"Kurtzke","year":"2015","unstructured":"Kurtzke, J. F. On the origin of EDSS. Mult Scler Related Disord. 4 (2), 95-103 (2015).","journal-title":"Mult Scler Related Disord"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"104517","DOI":"10.1016\/j.msard.2023.104517","type":"journal-article","article-title":"Clinical characteristics of late-onset neuromyelitis optica spectrum disorder","volume":"70","author":"Min","year":"2023","unstructured":"Min, W. et al. Clinical characteristics of late-onset neuromyelitis optica spectrum disorder. Mult Scler Related Disord. 70, 104517 (2023).","journal-title":"Mult Scler Related Disord"},{"issue":"1","key":"ref31","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1186\/s12877-020-01801-7","type":"journal-article","article-title":"A scoping review of the Clinical Frailty Scale","volume":"20","author":"Church","year":"2020","unstructured":"Church, S., Rogers, E., Rockwood, K., Theou, O. A scoping review of the Clinical Frailty Scale. BMC Geriatrics. 20 (1), 393 (2020).","journal-title":"BMC Geriatrics"},{"issue":"5","key":"ref32","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1007\/s11136-020-02727-8","type":"journal-article","article-title":"Response-shift effects in neuromyelitis optica spectrum disorder: estimating response-shift-adjusted scores using equating","volume":"30","author":"Schwartz","year":"2021","unstructured":"Schwartz, C. E., Stark, R. B., Stucky, B. D., Li, Y., Rapkin, B. D. Response-shift effects in neuromyelitis optica spectrum disorder: estimating response-shift-adjusted scores using equating. Quality Life Res. 30 (5), 1283-1292 (2021).","journal-title":"Quality Life Res"},{"issue":"9","key":"ref33","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1038\/sc.2012.33","type":"journal-article","article-title":"Validity of the mental health subscale of the SF-36 in persons with spinal cord injury","volume":"50","author":"van Leeuwen","year":"2012","unstructured":"van Leeuwen, C. M. C., van der Woude, L. H. V., Post, M. W. M. Validity of the mental health subscale of the SF-36 in persons with spinal cord injury. Spinal Cord. 50 (9), 707-710 (2012).","journal-title":"Spinal Cord"},{"issue":"6092","key":"ref34","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/324073a0","type":"journal-article","article-title":"Complementary DNA for a novel human interleukin (BSF-2) that induces B lymphocytes to produce immunoglobulin","volume":"324","author":"Hirano","year":"1986","unstructured":"Hirano, T. et al. Complementary DNA for a novel human interleukin (BSF-2) that induces B lymphocytes to produce immunoglobulin. Nature. 324 (6092), 73-76 (1986).","journal-title":"Nature"},{"issue":"1","key":"ref35","doi-asserted-by":"crossref","first-page":"71","DOI":"10.3109\/00207450903428970","type":"journal-article","article-title":"Enhanced IL-6 Production in Aquaporin-4 Antibody Positive Neuromyelitis Optica Patients","volume":"120","author":"I\u00e7\u00f6z","year":"2010","unstructured":"I\u00e7\u00f6z, S. et al. Enhanced IL-6 Production in Aquaporin-4 Antibody Positive Neuromyelitis Optica Patients. Int J Neurosci. 120 (1), 71-7 (2010).","journal-title":"Int J Neurosci"},{"issue":"1","key":"ref36","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1186\/s12974-017-0961-z","type":"journal-article","article-title":"Increased frequency of IL-6-producing non-classical monocytes in neuromyelitis optica spectrum disorder","volume":"14","author":"Kong","year":"2017","unstructured":"Kong, B. S. et al. Increased frequency of IL-6-producing non-classical monocytes in neuromyelitis optica spectrum disorder. J Neuroinflammat. 14 (1), 191 (2017).","journal-title":"J Neuroinflammat"},{"issue":"10","key":"ref37","doi-asserted-by":"crossref","first-page":"2731","DOI":"10.1172\/JCI25141","type":"journal-article","article-title":"IL-6 induces regionally selective spinal cord injury in patients with the neuroinflammatory disorder transverse myelitis","volume":"115","author":"Kaplin","year":"2005","unstructured":"Kaplin, A. I. et al. IL-6 induces regionally selective spinal cord injury in patients with the neuroinflammatory disorder transverse myelitis. J Clin Investigat. 115 (10), 2731-2741 (2005).","journal-title":"J Clin Investigat"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"104315","DOI":"10.1016\/j.neuint.2018.10.012","type":"journal-article","article-title":"Blockade of IL-6 signaling in neuromyelitis optica","volume":"130","author":"Araki","year":"2019","unstructured":"Araki, M. Blockade of IL-6 signaling in neuromyelitis optica. Neurochem Int. 130, 104315 (2019).","journal-title":"Neurochem Int"},{"issue":"2","key":"ref39","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s00011-015-0896-8","type":"journal-article","article-title":"Cytokines and matrix metalloproteinases in the cerebrospinal fluid of patients with acute transverse myelitis: an outcome analysis","volume":"65","author":"Dixit","year":"2016","unstructured":"Dixit, P. et al. Cytokines and matrix metalloproteinases in the cerebrospinal fluid of patients with acute transverse myelitis: an outcome analysis. Inflammat Res. 65 (2), 125-132 (2016).","journal-title":"Inflammat Res"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"1430080","DOI":"10.3389\/fnmol.2024.1430080","type":"journal-article","article-title":"Interleukin-10 contrasts inflammatory synaptopathy and central neurodegenerative damage in multiple sclerosis","volume":"17","author":"Gilio","year":"2024","unstructured":"Gilio, L. et al. Interleukin-10 contrasts inflammatory synaptopathy and central neurodegenerative damage in multiple sclerosis. Front Mol Neurosci. 17, 1430080 (2024).","journal-title":"Front Mol Neurosci"},{"issue":"14","key":"ref41","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.3390\/cells13141205","type":"journal-article","article-title":"The Novel Cytokine Interleukin-41\/Meteorin-like Is Reduced in Diffuse Systemic Sclerosis","volume":"13","author":"Freedman","year":"2024","unstructured":"Freedman, P., Schock, B., O'Reilly, S. The Novel Cytokine Interleukin-41\/Meteorin-like Is Reduced in Diffuse Systemic Sclerosis. Cells. 13 (14), 1205 (2024).","journal-title":"Cells"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"112275","DOI":"10.1016\/j.intimp.2024.112275","type":"journal-article","article-title":"Increased serum interleukin-41 correlates with disease severity in myasthenia gravis","volume":"134","author":"Wang","year":"2024","unstructured":"Wang, Z. et al. Increased serum interleukin-41 correlates with disease severity in myasthenia gravis. Int Immunopharmacol. 134, 112275 (2024).","journal-title":"Int Immunopharmacol"},{"key":"ref43","first-page":"830029","type":"journal-article","article-title":"Myelitis: A Common Complication of Tuberculous Meningitis Predicting Poor Outcome","volume":"13","author":"Jiang","year":"2022","unstructured":"Jiang, Y. et al. Myelitis: A Common Complication of Tuberculous Meningitis Predicting Poor Outcome. Front Neurol. 13 830029 (2022).","journal-title":"Neurol"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"106209","DOI":"10.1016\/j.msard.2024.106209","type":"journal-article","article-title":"Relapse risk factors analysis within 1 year after the first onset of neuromyelitis optica spectrum disorders: A two-center retrospective study","volume":"93","author":"Li","year":"2025","unstructured":"Li, H., Jiang, Y., Zhang, Y., Xu, D., Zhang, Y. Relapse risk factors analysis within 1 year after the first onset of neuromyelitis optica spectrum disorders: A two-center retrospective study. Mult Scler Related Disord. 93, 106209 (2025).","journal-title":"Mult Scler Related Disord"},{"issue":"11","key":"ref45","doi-asserted-by":"crossref","first-page":"5430","DOI":"10.7150\/thno.53961","type":"journal-article","article-title":"Sialylated immunoglobulin G: a promising diagnostic and therapeutic strategy for autoimmune diseases","volume":"11","author":"Li","year":"2021","unstructured":"Li, D. et al. Sialylated immunoglobulin G: a promising diagnostic and therapeutic strategy for autoimmune diseases. Theranostics. 11 (11), 5430-5446 (2021).","journal-title":"Theranostics"}],"container-title":["Journal of Visualized Experiments"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/app.jove.com\/t\/69263\/influence-efgartigimod-on-curative-efficacy-inflammation-factors","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T13:55:09Z","timestamp":1792590909000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jove.com\/t\/69263\/influence-efgartigimod-on-curative-efficacy-inflammation-factors"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,6]]},"references-count":45,"journal-issue":{"issue":"227","published-online":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.3791\/69263","relation":{},"ISSN":["1940-087X"],"issn-type":[{"value":"1940-087X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,6]]}}}